BioLight Life (Israel) Buy Hold or Sell Recommendation

BOLT -- Israel Stock  

ILS 1,404  25.00  1.81%

Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding BioLight Life Sciences Ltd is 'Cautious Hold'. Macroaxis provides BioLight Life buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BOLT positions. The advice algorithm takes into account all of BioLight Life Sciences available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from BOLT buy-and-hold prospective. Check also BioLight Life Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Symbol
Execute Advice
Sell BioLight LifeBuy BioLight Life
Cautious Hold

Volatility

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Not Available
For the selected time horizon BioLight Life Sciences Ltd has a mean deviation of 1.58, semi deviation of 0.0, standard deviation of 2.26, variance of 5.09, downside variance of 0.0 and semi variance of 0.0
Macroaxis provides buy, hold, or sell suggestion on BioLight Life Sciences to complement and cross-verify current analyst consensus on BioLight Life Sciences Ltd. Our buy, hold, or sell recommendation engine determines the organization potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure BioLight Life is not overpriced, please confirm all BioLight Life Sciences fundamentals including its Price to Book, Revenue, EBITDA, as well as the relationship between Price to Sales and Gross Profit .

BioLight Life Returns Distribution Density

Mean Return0.02Value At Risk3.84
Potential Upside3.45Standard Deviation2.26
 Return Density 
      Distribution 

BioLight Life Greeks

α
Alpha over DOW
=0.03
β
Beta against DOW=0.05
σ
Overall volatility
=2.42
Ir
Information ratio =0.0367

BioLight Life Volatility Alert

BioLight Life Sciences Ltd exhibits very low volatility with skewness of -0.27 and kurtosis of 1.35. However, we advise investors to further study BioLight Life Sciences Ltd technical indicators to make sure all market info is available and is reliable.
    
 Better Than Average     
    
 Worse Than Average Compare BioLight Life to competition

BioLight Life Fundamental Vs Peers

FundamentalsBioLight LifePeer Average
Return On Equity(100.72)% (15.17)%
Return On Asset(36.45)% (15.64)%
Operating Margin(583.89)% (10.91)%
Current Valuation39.69M152.14B
Shares Outstanding4.54M1.43B
Price to Earning(225.34)X40.69X
Price to Book509.25X14.44X
Price to Sales15.32X17.81X
Revenue4.16M9.85B
Gross Profit450K21.75B
EBITDA(23.98M)1.41B
Net Income(13.8M)517.71M
Cash and Equivalents39.18M3.89B
Cash per Share9.40X5.17X
Current Ratio6.55X3.30X
Book Value Per Share2.76X13.64X
Cash Flow from Operations(25.3M)1.25B
Earnings Per Share(3.62)X2.30X
Number of Employees2410.67K
Beta0.310.34
Market Capitalization63.78M29.78B
Total Asset53M126.86B
Retained Earnings(218M)38.24B
Working Capital39M3.58B
Current Asset45M36.8B
Current Liabilities6M33.34B
Z Score-5.6708.73

BioLight Life Alerts

Trading Alerts and Improvement Suggestions

BioLight Life generates negative expected return over the last 30 days
BioLight Life has high likelihood to experience some financial distress in the next 2 years
The company reported revenue of 4.16M. Net Loss for the year was (13.8M) with profit before overhead, payroll, taxes, and interest of 450K.
BIO LIGHT ISR LFE has accumulated about 39.18M in cash with (25.3M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.4.

Latest Analysts View

BioLight Life Current Analysts Recommendations

Target Median Price12.00
Target Mean Price12.00
Target High Price12.00
Number Of Analyst Opinions1
Target Low Price12.00
Check also BioLight Life Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool. Please also try Price Transformation module to use price transformation models to analyze depth of different equity instruments across global markets.
Search macroaxis.com